in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..
scottish widows demands auto-enrolment threshold is scrapped...: "arise: a phase 3 randomized trial of erenumab for episodic migraine.".